Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2015

Open Access 01-12-2015 | Study protocol

Peer-led healthy lifestyle program in supportive housing: study protocol for a randomized controlled trial

Authors: Leopoldo J. Cabassa, Ana Stefancic, Kathleen O’Hara, Nabila El-Bassel, Roberto Lewis-Fernández, José A. Luchsinger, Lauren Gates, Richard Younge, Melanie Wall, Lara Weinstein, Lawrence A. Palinkas

Published in: Trials | Issue 1/2015

Login to get access

Abstract

Background

The risk for obesity is twice as high in people with serious mental illness (SMI) compared to the general population. Racial and ethnic minority status contribute additional health risks. The aim of this study is to describe the protocol of a Hybrid Trial Type 1 design that will test the effectiveness and examine the implementation of a peer-led healthy lifestyle intervention in supportive housing agencies serving diverse clients with serious mental illness who are overweight or obese.

Methods

The Hybrid Trial Type 1 design will combine a randomized effectiveness trial with a mixed-methods implementation study. The effectiveness trial will test the health impacts of a peer-led healthy lifestyle intervention versus usual care in supportive housing agencies. The healthy lifestyle intervention is derived from the Group Lifestyle Balanced Program, lasts 12 months, and will be delivered by trained peer specialists. Repeated assessments will be conducted at baseline and at 6, 12, and 18 months post randomization. A mixed-methods (e.g., structured interviews, focus groups, surveys) implementation study will be conducted to examine multi-level implementation factors and processes that can inform the use of the healthy lifestyle intervention in routine practice, using data from agency directors, program managers, staff, and peer specialists before, during, and after the implementation of the effectiveness trial.

Discussion

This paper describes the use of a hybrid research design that blends effectiveness trial methodologies and implementation science rarely used when studying the physical health of people with SMI and can serve as a model for integrating implementation science and health disparities research. Rigorously testing effectiveness and exploring the implementation process are both necessary steps to establish the evidence for large-scale delivery of peer-led healthy lifestyle intervention to improve the physical health of racial/ethnic minorities with SMI.

Trial registration

www.​clinicaltrials.​gov; NCT02175641, registered 24 June 2014
Literature
1.
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry. 2004;65:267–72.CrossRef
2.
Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: a National Institute of Mental Health meeting report. Am J Prev Med. 2009;36:341–50.CrossRefPubMed
3.
Goff DC, Sullivan LM, McEvoy JP, Meyer JM, Nasrallah HA, Daumit GL, et al. A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls. Schizophr Res. 2005;80:45–53.CrossRefPubMed
4.
McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L, et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res. 2005;80:19–32.CrossRefPubMed
5.
Dixon L, Weiden P, Delahanty J, Goldberg R, Postrado L, Lucksted A, et al. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull. 2000;26:903–12.CrossRefPubMed
6.
Hellerstein DJ, Almeida G, Devlin MJ, Mendelsohn N, Helfand S, Dragatsi D, et al. Assessing obesity and other related health problems of mentally ill Hispanic patients in an urban outpatient setting. Psychiatr Q. 2007;78:171–81.CrossRefPubMed
7.
Kato MM, Currier MB, Gomez CM, Hall L, Gonzalez-Blanco M. Prevalence of metabolic syndrome in hispanic and non-hispanic patients with schizophrenia. Prim Care Companion J Clin Psychiatry. 2004;6:74–7.CrossRefPubMedPubMedCentral
8.
Stecker T, Fortney JC, Steffick DE, Prajapati S. The triple threat for chronic disease: obesity, race, and depression. Psychosomatics. 2006;47:513–8.CrossRefPubMed
9.
Henderson DC, Nguyen DD, Copeland PM, Hayden DL, Borba CP, Louie PM, et al. Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study. J Clin Psychiatry. 2005;66:1116–21.CrossRefPubMed
10.
Carliner H, Collins PY, Cabassa LJ, McNallen A, Joestl SS, Lewis-Fernández R. Prevalence of cardiovascular risk factors among racial and ethnic minorities with schizophrenia spectrum and bipolar disorders: a critical literature review. Compr Psychiat In press.
11.
Institute of Medicine. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC; 2003.
12.
Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med. 1999;29:697–701.CrossRefPubMed
13.
Daumit GL, Goldberg RW, Anthony C, Dickerson F, Brown CH, Kreyenbuhl J, et al. Physical activity patterns in adults with severe mental illness. J Nerv Ment Dis. 2005;193:641–6.CrossRefPubMed
14.
Druss BG, Zhao L, Von Esenwein S, Morrato EH, Marcus SC. Understanding excess mortality in persons with mental illness: 17-year follow up of a nationally representative US survey. Med Care. 2011;49:599–604.CrossRefPubMed
15.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.CrossRefPubMed
16.
The Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcome study. The Lancet. 2009;6736:61457–64.
17.
Lipscomb ER, Finch EA, Brizendine E, Saha CK, Hays LM, Ackermann RT. Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: the DEPLOY pilot study. Diabetes Care. 2009;32:394–6.CrossRefPubMedPubMedCentral
18.
Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community, The DEPLOY Pilot Study. Am J Prev Med. 2008;35:357–63.CrossRefPubMedPubMedCentral
19.
Katula JA, Vitolins MZ, Rosenberger EL, Blackwell C, Espeland MA, Lawlor MS, et al. Healthy Living Partnerships to Prevent Diabetes (HELP PD): design and methods. Contemp Clin Trials. 2010;31:71–81.CrossRefPubMed
20.
Kramer MK, Kriska AM, Venditti EM, Miller RG, Brooks MM, Burke LE, et al. Translating the Diabetes Prevention Program: a comprehensive model for prevention training and program delivery. Am J Prev Med. 2009;37:505–11.CrossRefPubMed
21.
Venditti EM, Kramer MK. Necessary components for lifestyle modification interventions to reduce diabetes risk. Curr Diab Rep. 2012;12:138–46.CrossRefPubMed
22.
Cabassa LJ, Ezell JM, Lewis-Fernandez R. Lifestyle interventions for adults with serious mental illness: a systematic literature review. Psychiatric Serv. 2010;61:774–82.CrossRef
23.
Verhaeghe N, De Maeseneer J, Maes L, Van Heeringen C, Annemans L. Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act. 2011;8:28.CrossRefPubMedPubMedCentral
24.
Alvarez-Jimenez M, Hetrick SE, Gonzalez-Blanch C, Gleeson JF, McGorry PD. Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2008;193:101–7.CrossRefPubMed
25.
Bartels SJ, Desilets RA. Health promotion programs for persons with serious mental illness: what works? A systematic review and analysis of the evidence base in published research literature on exercise and nutrition programs. Washington, DC: SAMHSA-HRSA Center for Integrated Health Solutions; 2012.
26.
Green CA, Yarborough BJ, Leo MC, Yarborough MT, Stumbo SP, Janoff SL, et al. The STRIDE weight loss and lifestyle intervention for individuals taking antipsychotic medications: a randomized trial. Am J Psychiatry. 2014;172(1):71–81.CrossRefPubMedPubMedCentral
27.
Daumit GL, Dickerson FB, Wang NY, Dalcin A, Jerome GJ, Anderson CA, et al. A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med. 2013;368(17):1594–602.CrossRefPubMedPubMedCentral
28.
Mangurian C, Chaudhry S, Capitelli L, Amiel J, Rosario F, Jackson C, et al. Implementation of a weight loss program for Latino outpatients with severe mental illness. Community Ment Health J. 2013;49:150–6.CrossRefPubMed
29.
Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA. 2007;298:1794–6.CrossRefPubMed
30.
Morden NE, Mistler LA, Weeks WB, Bartels SJ. Health care for patients with serious mental illness: family medicine’s role. J Am Board Fam Med. 2009;22:187–95.CrossRefPubMedPubMedCentral
31.
Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53:1925–32.CrossRefPubMed
32.
Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, et al. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med. 2001;134:1–11.CrossRefPubMed
33.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefPubMed
34.
US Department of Health and Human Services. Physical activity and health: a report from the Surgeon General. Atlanta, Georgia: US Government Printing Office; 1996.
35.
Ross R, Janiszewski PM. Is weight loss the optimal target for obesity-related cardiovascular disease risk reduction? Can J Cardiol. 2008;24:25–31.CrossRef
36.
Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 2011;40:1382–400.CrossRefPubMed
37.
Ali MK, Echouffo-Tcheugui J, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff (Millwood). 2012;31:67–75.CrossRef
38.
Thorpe KE. Analysis and commentary: The Affordable Care Act lays the groundwork for a national diabetes prevention and treatment strategy. Health Aff (Millwood). 2012;31:61–6.CrossRef
39.
Repper J, Carter T. A review of the literature on peer support in mental health services. J Ment Health. 2011;20:392–411.CrossRefPubMed
40.
Chinman M, Oberman RS, Hanusa BH, Cohen AN, Salyers MP, Twamley EW, Young AS. A cluster randomized trial of adding peer specialists to intensive case management teams in the Veterans Health Administration. J Behav Health Serv Res. 2015;42:109-21.
41.
National Association of State Mental Health Program Directors. Enhancing the peer provider workforce: recruitment, supervision and retention. Alexandria, Virginia: National Association of State Mental Health Program Directors (NASMHPD); 2014.
42.
Lorig K, Ritter PL, Villa FJ, Armas J. Community-based peer-led diabetes self-management: a randomized trial. Diabetes Educ. 2009;35:641–51.CrossRefPubMed
43.
Ayala GX, Vaz L, Earp JA, Elder JP, Cherrington A. Outcome effectiveness of the lay health advisor model among Latinos in the United States: an examination by role. Health Educ Res. 2010;25:815–40.CrossRefPubMedPubMedCentral
44.
Dohan D, Schrag D. Using navigators to improve care of underserved patients. Cancer. 2005;104:848–55.CrossRefPubMed
45.
Bradford JB, Coleman S, Cunningham W. HIV system navigation: an emerging model to improve HIV care access. AIDS Patient Care STDs. 2007;21 Suppl 1:S49–58.PubMed
46.
Brownson CA, Heisler M. The role of peer support in diabetes care and self-management. Patient. 2009;2:5–17.CrossRefPubMed
47.
Cook JA. Peer-delivered wellness recovery services: from evidence to widespread implementation. Psychiatr Rehabil J. 2011;35:87–9.CrossRefPubMed
48.
Druss BG, Zhao L, von Esenwein SA, Bona JR, Fricks L, Jenkins-Tucker S, et al. The Health and Recovery Peer (HARP) Program: a peer-led intervention to improve medical self-management for persons with serious mental illness. Schizophr Res. 2010;118:264–70.CrossRefPubMedPubMedCentral
49.
Henwood BF, Cabassa LJ, Craig CM, Padgett DK. Permanent supportive housing: addressing homelessness and health disparities? Am J Public Health. 2013;103 Suppl 2:S188–92.CrossRefPubMedPubMedCentral
50.
51.
U.S. Department of Housing and Urban Development. The 2013 Annual Homeless Assessment Report to Congress. Washington, DC: US Department of Housing and Urban Development; 2013.
52.
Henwood BF, Weinstein LC, Tsemberis S. Creating a medical home for homeless persons with serious mental illness. Psychiatr Serv. 2011;62:561–2.CrossRefPubMed
53.
Weinstein LC, Henwood BF, Matejkowski J, Santana AJ. Moving from street to home: health status of entrants to a housing first program. J Prim Care Community Health. 2011;2:11–5.CrossRefPubMed
54.
Cabassa LJ, Parcesepe A, Nicasio A, Baxter E, Tsemberis S, Lewis-Fernandez R. Health and wellness photovoice project: engaging consumers with serious mental illness in health care interventions. Qual Health Res. 2013;23:618–30.CrossRefPubMed
55.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50:217–26.CrossRefPubMedPubMedCentral
56.
Gates LB, Akabas SH. Developing strategies to integrate peer providers into the staff of mental health agencies. Adm Policy Ment Health. 2007;34:293–306.CrossRefPubMed
57.
Herbert M, Rosenheck R, Drebing C, Young AS, Armstrong M. Integrating peer support initiatives in a large healthcare organization. Psychol Serv. 2008;5:216–77.CrossRef
58.
Chinman M, Young AS, Hassell J, Davidson L. Toward the implementation of mental health consumer provider services. J Behav Health Serv Res. 2006;33:176–95.CrossRefPubMed
59.
Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011;38:65–76.CrossRefPubMed
60.
Glisson C, Landsverk J, Schoenwald S, Kelleher K, Hoagwood KE, Mayberg S, et al. Assessing the organizational social context (OSC) of mental health services: implications for research and practice. Adm Policy Ment Health. 2008;35:98–113.CrossRefPubMed
61.
Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50.CrossRefPubMedPubMedCentral
62.
Gearing RE, El-Bassel N, Ghesquiere A, Baldwin S, Gillies J, Ngeow E. Major ingredients of fidelity: a review and scientific guide to improving quality of intervention research implementation. Clin Psychol Rev. 2011;31:79–88.CrossRefPubMed
63.
Allen JD, Linnan LA, Emmons KM. Fidelity and its relationship to implementation effectiveness, adaptation, and dissemination. In: Brownson RC, Colditz GA, Proctor EK, editors. Dissemination and implementation research in health: translating science to practice. New York: Oxford University Press; 2012. p. 281–304.CrossRef
64.
West DS, Elaine PT, Bursac Z, Felix HC. Weight loss of Black, White, and Hispanic men and women in the diabetes prevention program. Obesity. 2008;16:1413–20.CrossRefPubMed
65.
Aarons GA, Glisson C, Green PD, Hoagwood K, Kelleher KJ, Landsverk JA, et al. The organizational social context of mental health services and clinician attitudes toward evidence-based practice: a United States national study. Implement Sci. 2012;7:56.CrossRefPubMedPubMedCentral
66.
Williams J, Leamy M, Bird V, Harding C, Larsen J, Le Boutillier C, et al. Measures of the recovery orientation of mental health services: systematic review. Soc Psychiatry Psychiatr Epidemiol. 2012;47:1827–35.CrossRefPubMed
67.
68.
Aarons GA, Horowitz JD, Dlugosz LR, Ehrhart MG. The role of organizational processes in dissemination and implementation research. In: Brownson RC, Colditz GA, Proctor EK, editors. Dissemination and implementation research in health: translating science to practice. New York: Oxford University Press; 2012. p. 128–53.CrossRef
69.
Aarons GA, McDonald EJ, Sheehan AK, Walrath-Greene CM. Confirmatory factor analysis of the Evidence-Based Practice Attitude Scale in a geographically diverse sample of community mental health providers. Adm Policy Ment Health. 2007;34:465–9.CrossRefPubMed
70.
Rogers EM. Diffusions of innovations. 4th ed. New York: Free Press; 1995.
71.
Tsemberis S, Gulcur L, Nakae M. Housing First, consumer choice, and harm reduction for homeless individuals with a dual diagnosis. Am J Public Health. 2004;94:651–6.CrossRefPubMedPubMedCentral
72.
Stefancic A, Tsemberis S. Housing First for long-term shelter dwellers with psychiatric disabilities in a suburban county: a four-year study of housing access and retention. J Prim Prev. 2007;28:265–79.CrossRefPubMed
73.
The Diabetes Prevention Program Research Group. The diabetes prevention program: description of lifestyle intervention. Diabetes Care. 2002;25:2165–71.CrossRef
74.
Food and Drug Administration FR. International conference on harmonization: guidelines on general considerations for clinical trials. Fed Reg. 1997;62:66113–9.
75.
Panel on Handling Missing Data in Clinical Trials: The prevention and treatment of missing data in clinical trials. Washington, DC: National Research Council; 2010.
76.
Little RJ, Wang Y. Pattern-mixture models for multivariate incomplete data with covariates. Biometrics. 1996;52:98–111.CrossRefPubMed
77.
78.
Lagakos S. The challenge of subgroup analyses: reporting without distorting. New Engl J Med. 2006;354:1667–9.CrossRefPubMed
79.
O’Connell M, Tondora J, Croog G, Evans A, Davidson L. From rhetoric to routine: assessing perceptions of recovery-oriented practices in a state mental health and addiction system. Psychiatr Rehabil J. 2005;28:378–86.CrossRefPubMed
80.
Creswell JW. Research design: qualitative, quantitative and mixed methods approaches. 2nd ed. Thousand Oaks: Sage Publications; 2003.
81.
DeWalt KM, DeWalt BR. Participant observation: a guide for fieldworkers. Lanham: Rowman Altamira; 2010.
82.
Bernard HR. Research methods in anthropology: qualitative and quantitative approaches. 3rd ed. Walnut Creek: AltaMira Press; 2002.
83.
Emerson RM, Fretz RI, Shaw LL. Writing ethnographic fieldnotes. Chicago: University of Chicago Press; 2011.CrossRef
84.
Strauss AL, Corbin J. Basics of qualitative research: techniques and procedures for developing grounded theory. 2nd ed. Thousand Oaks: Sage; 1998.
85.
Geertz C. The interpretation of cultures. New York: Basic Books; 2000.
86.
Fereday J, Muir-Cochrane E. Demonstrating rigor using thematic analysis: a hybrid approach of inductive and deductive coding and theme development. Int J Qual Methods. 2006;5:80–92.
87.
Crabtree BF, Miller WL. A template approach to text analysis: developing and using codebooks. In: Crabtree BF, Miller WL, editors. Doing qualitative research, vol. 3. Thousand Oaks: Sage Press; 1992. p. 93–109.
88.
Zayas LH, Cabassa LJ, Pérez MC. Capacity-to-consent in psychiatric research: Development and preliminary testing of a screening tool. Res Soc Work Pract. 2005;15:545–56.CrossRef
89.
Palmer RM, Meldon SW. Acute care. In: Hazzard WR, editor. Principles of geriatric medicine and gerontology. Boston: McGraw-Hill; 2003. p. 157–68.
90.
Dutton GR, Martin PD, Rhode PC, Brantley PJ. Use of the weight efficacy lifestyle questionnaire with African American women: validation and extension of previous findings. Eat Behav. 2004;5:375–84.CrossRefPubMed
91.
Wallston KA. The validity of the multidimensional health locus of control scales. J Health Psychol. 2005;10:623–31.CrossRefPubMed
92.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRefPubMed
93.
Faulkner G, Cohn T, Remington G. Validation of a physical activity assessment tool for individuals with schizophrenia. Schizophr Res. 2006;82:225–31.CrossRefPubMed
94.
Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD: Journal of Chronic Obstructive Pulmonary Diseases. 2005;2:125–9.CrossRef
95.
Bartels SJ, Pratt SI, Aschbrenner KA, Barre LK, Jue K, Wolfe RS, et al. Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv. 2013;64:729–36.CrossRefPubMed
96.
Lalonde I, Graham M, Slovinec-D’angelo M, Beaton L, Brown J, Block T. Validation of the block fat/sugar/fruit/vegetable screener in a cardiac rehabilitation setting. J Cardiopulm Rehabil Prev. 2008;28:340.CrossRef
97.
Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System Survey Questionnaire. Atlanta, Georgia; 2013.
98.
Corrigan PW, Salzer M, Ralph RO, Sangster Y, Keck L. Examining the factor structure of the recovery assessment scale. Schizophr Bull. 2004;30:1035–41.CrossRefPubMed
99.
Ware Jr J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–33.CrossRefPubMed
100.
Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and validity of the SF-12 health survey among people with severe mental illness. Med Care. 2000;38:1141–50.CrossRefPubMed
101.
Roberts R, Atkinson C, Mendías R. Assessing the Client Satisfaction Questionnaire in English and Spanish. Hisp J Behav Sci. 1984;6:385–95.CrossRef
102.
Eisen SV, Normand SL, Belanger AJ, Spiro 3rd A, Esch D. The Revised Behavior and Symptom Identification Scale (BASIS-R): reliability and validity. Med Care. 2004;42:1230–41.CrossRefPubMed
103.
Marin GS, Gamba RJ. A new measurement of acculturation for Hispanics: the bidimensional acculturation scale for Hispanics (BAS). Hisp J Behav Sci. 1996;18:297–316.CrossRef
104.
Cabassa LJ, Zayas LH. Latino immigrants’ intentions to seek depression care. Am J Orthopsychiatr. 2007;77:231–42.CrossRef
105.
Manos MM, Leyden WA, Resendez CI, Klein EG, Wilson TL, Bauer HM. A community-based collaboration to assess and improve medical insurance status and access to health care of Latino children. Public Health Rep. 2001;116:575–84.CrossRefPubMedPubMedCentral
106.
Cacciola JS, Alterman AI, McLellan AT, Lin YT, Lynch KG. Initial evidence for the reliability and validity of a “Lite” version of the Addiction Severity Index. Drug Alcohol Depend. 2007;87:297–302.CrossRefPubMed
Metadata
Title
Peer-led healthy lifestyle program in supportive housing: study protocol for a randomized controlled trial
Authors
Leopoldo J. Cabassa
Ana Stefancic
Kathleen O’Hara
Nabila El-Bassel
Roberto Lewis-Fernández
José A. Luchsinger
Lauren Gates
Richard Younge
Melanie Wall
Lara Weinstein
Lawrence A. Palinkas
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Trials / Issue 1/2015
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-015-0902-z

Other articles of this Issue 1/2015

Trials 1/2015 Go to the issue

Study protocol

Effects of Shinbaro pharmacopuncture in sciatic pain patients with lumbar disc herniation: study protocol for a randomized controlled trial

Study protocol

Evaluating the use of fibrin glue for sealing low-output enterocutaneous fistulas: study protocol for a randomized controlled trial

Study protocol

Nortriptyline in knee osteoarthritis (NortIKA Study): study protocol for a randomised controlled trial

Commentary

Recruiting to inpatient-based rehabilitation trials: lessons learned

Research

Logistic, ethical, and political dimensions of stepped wedge trials: critical review and case studies

Study protocol

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial